The Niche Stem Cell & Regen Med Website

We have a new post today!

2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best

A quick review of the publicly-traded stem cell stocks I've been following in 2021 finds mostly discouraging news, but a few firms relatively outperformed the other publically-traded biotechs. One had some great news today. In this post, I'm doing a brief overview of how things went this year in the regenerative medicine space. I'm going to feature Lineage Cell Therapeutics …
Mesoblast stock